Drawing for LYELL

USPTO serial 88228691

LYELL

Reviewed by CopyMark Law Group

Reg. 7207833Status 700Registered
Filing date
Status date
Registration date
Oct 31, 2023
Examiner
PARKER, JUSTINE D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LYELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, NW, 10th FloorWashington, DC 20005United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposesACTIVEJan 5, 2023
042Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific researchACTIVESep 19, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 25, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 25, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 28, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 27, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 19, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 18, 2023IUAFUSE AMENDMENT FILED—
Aug 18, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 15, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 14, 2023EX5GSOU EXTENSION 5 GRANTED—
Feb 13, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 27, 2023EXT5SOU EXTENSION 5 FILED—
Jan 27, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2022EX4GSOU EXTENSION 4 GRANTED—
Jul 28, 2022EXT4SOU EXTENSION 4 FILED—
Jul 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 19, 2022EX3GSOU EXTENSION 3 GRANTED—
Jan 19, 2022EXT3SOU EXTENSION 3 FILED—
Jan 19, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 1, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 1, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 1, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 7, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 5, 2021EX2GSOU EXTENSION 2 GRANTED—
Aug 5, 2021EXT2SOU EXTENSION 2 FILED—
Aug 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 31, 2020EX1GSOU EXTENSION 1 GRANTED—
Dec 31, 2020EXT1SOU EXTENSION 1 FILED—
Dec 31, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 25, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 30, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 12, 2020PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 27, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 24, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 24, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 15, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 15, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 15, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 31, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 31, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 8, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 8, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 7, 2019ALIEASSIGNED TO LIE—
Oct 1, 2019NREVNOTICE OF REVIVAL - E-MAILED—
Oct 1, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 1, 2019PETGPETITION TO REVIVE-GRANTED—
Oct 1, 2019PROATEAS PETITION TO REVIVE RECEIVED—
Mar 19, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 12, 2019DOCKASSIGNED TO EXAMINER—
Jan 5, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance